Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Dementia risk for bipolar disorder patients

Patients with bipolar disorder are at increased risk for developing dementia, both pre-senile and senile, a study of a nationwide dataset in Taiwan confirms.

4 Sep 2013

Proteins in blood predict women at risk of pre-eclampsia during first pregnancy

Researchers from The University of Manchester and Central Manchester University Hospitals NHS Trust have identified proteins in the blood that could be used to predict whether a woman in her first pregnancy is at increased risk of developing pre-eclampsia.

From The University of Manchester 4 Sep 2013

Study confirms Mediterranean diet associated with better cognitive function

Over recent years many pieces of research have identified a link between adherence to a Mediterranean diet and a lower risk of age-related disease such as dementia.

4 Sep 2013

Avanir Pharmaceuticals enters into patent settlement agreement with Actavis

Avanir Pharmaceuticals, Inc. today announced that it has entered into a settlement agreement with Actavis South Atlantic LLC and Actavis, Inc. (collectively, "Actavis") to resolve pending patent litigation in response to Actavis' abbreviated new drug application seeking approval to market generic versions of Avanir's NUEDEXTA (dextromethorphan hydrobromide/quinidine sulfate) capsules.

4 Sep 2013

Proteins in blood could predict woman at increased risk of developing pre-eclampsia

3 Sep 2013

Study finds that high potency statins can beat dementia

Dr Lin said: "Statins are widely used in the older population to reduce the risk of cardiovascular disease. But recent reports of statin-associated cognitive impairment have led the US Food and Drug Administration (FDA) to list statin-induced cognitive changes, especially for the older population, in its safety communications."

2 Sep 2013

Viewpoints: Tying 'social safeguards' to work may not be best policy; GOP missing an opportunity by not offering alternative to health law; food makers' health claims 'hard to swallow'

In May, the head of [Trader Joe's] ... sent a confidential memo to employees notifying them of changes to their health coverage, retirement program and wages. ... He pledged to reduce workers' healthcare costs 10% for the remainder of the year while the company determines its response to changes under the Affordable Care Act. ...

31 Aug 2013

Still no evidence for causes of Alzheimer's disease by playing football, despite NFL settlement

Despite the NFL's $765 million settlement with retired players, there still is no credible scientific evidence that playing football causes Alzheimer's disease or other neurological disorders, according to Loyola University Medical Center clinical neuropsychologist Christopher Randolph, PhD, who has published multiple studies on the topic.

31 Aug 2013

NIHR recognizes Plymouth Hospitals for promoting clinical research in NHS

Healthcare professionals and academic researchers will have the opportunity to hear from research teams at Plymouth Hospitals NHS Trust and its research partners next month.

30 Aug 2013

Research team examines link between genetics and memory problems in Parkinson's patients

A research team at University of Virginia School of Medicine led by Matthew Barrett, MD, MSc, will use a state grant to examine the link between genetics and memory problems in Parkinson's disease patients. Barrett hopes the research will eventually lead to customized treatments for Parkinson's disease patients.

30 Aug 2013

Blood test provides tool essential to trials of therapies for Huntington's disease

An assay designed to measure normal and abnormal forms of the huntingtin protein - the mutated form of which causes Huntington's disease - was successful in detecting levels of the mutant protein in a large multicenter study of individuals at risk for the devastating neurological disorder.

30 Aug 2013

Future of biomedical innovation depends on new trend for all players to work together for common goal

It's a long, expensive, risky road to turn a scientific breakthrough into a treatment that can help patients. Fewer organizations are trying to tackle the challenges alone, says a new paper from MIT researchers published August 28 in the journal Science Translational Medicine.

29 Aug 2013

Study reveals relationship between migraine and low income status

Studies show that migraine is more common among people with lower incomes. This relationship is examined in a study published in the August 28, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology, looking at whether developing migraines limits people's educational and career achievements, leading to a lower income status, or whether problems related to low income such as stressful life events and poor access to health care increase the likelihood of developing migraines.

29 Aug 2013

Study shows that migraine may have long-term effects on the brain's structure

Migraine may have long-lasting effects on the brain's structure, according to a study published in the August 28, 2013, online issue of Neurology, the medical journal of the American Academy of Neurology.

29 Aug 2013

Study: Deficiency of protein causes age-related memory loss and Alzheimer's disease

A team of Columbia University Medical Center (CUMC) researchers, led by Nobel laureate Eric R. Kandel, MD, has found that deficiency of a protein called RbAp48 in the hippocampus is a significant contributor to age-related memory loss and that this form of memory loss is reversible.

29 Aug 2013

Researchers identify possible treatment strategy for ALS and other neurodegenerative disorders

Researchers have tied mutations in a gene that causes amyotrophic lateral sclerosis and other neurodegenerative disorders to the toxic buildup of certain proteins and related molecules in cells, including neurons. The research, published recently in the scientific journal Cell, offers a new approach for developing treatments against these devastating diseases.

29 Aug 2013

Alzheimer’s drug trial: an interview with Geoffrey Kempler, Chairman & CEO Prana Biotechnology

Approval for the IMAGINE trial was granted by the Austin Health Research Ethics Committee in November 2011, with the first patients dosed in March the following year. However, well before the trial was approved, PBT2 had already shown promise in significantly changing Abeta levels in spinal fluid while improving cognition in a previous 12-week trial conducted in 2006.

28 Aug 2013

Study paves way for understanding the crucial role of lncRNA in human neurons

Scientists at A*STAR's Genome Institute of Singapore have discovered an unusual gene that controls the generation of neurons. This important finding, which is crucial in understanding serious diseases of the brain such as Alzheimer's disease, was reported in the 8th August 2013 issue of the prestigious scientific journal, Molecular Cell.

28 Aug 2013

Research shows specific form of memory associations is encoded in cerebral cortex

'Where' and 'how' memories are encoded in a nervous system is one of the most challenging questions in biological research. The formation and recall of associative memories is essential for an independent life. The hippocampus has long been considered a centre in the brain for the long-term storage of spatial associations.

28 Aug 2013

Research Institute at Nationwide Children's Hospital to receive transition-to-scale grants

he Saving Lives at Birth: A Grand Challenge for Development recently shortlisted 53 finalists from around the world from more than 400 entries. Only 22 teams were awarded grants for their bold, new ideas to save the lives of mothers and newborns in developing countries.

27 Aug 2013

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Dementia risk for bipolar disorder patients

Proteins in blood predict women at risk of pre-eclampsia during first pregnancy

Study confirms Mediterranean diet associated with better cognitive function

Avanir Pharmaceuticals enters into patent settlement agreement with Actavis

Proteins in blood could predict woman at increased risk of developing pre-eclampsia

Study finds that high potency statins can beat dementia

Viewpoints: Tying 'social safeguards' to work may not be best policy; GOP missing an opportunity by not offering alternative to health law; food makers' health claims 'hard to swallow'

Still no evidence for causes of Alzheimer's disease by playing football, despite NFL settlement

NIHR recognizes Plymouth Hospitals for promoting clinical research in NHS

Research team examines link between genetics and memory problems in Parkinson's patients

Blood test provides tool essential to trials of therapies for Huntington's disease

Future of biomedical innovation depends on new trend for all players to work together for common goal

Study reveals relationship between migraine and low income status

Study shows that migraine may have long-term effects on the brain's structure

Study: Deficiency of protein causes age-related memory loss and Alzheimer's disease

Researchers identify possible treatment strategy for ALS and other neurodegenerative disorders

Alzheimer’s drug trial: an interview with Geoffrey Kempler, Chairman & CEO Prana Biotechnology

Study paves way for understanding the crucial role of lncRNA in human neurons

Research shows specific form of memory associations is encoded in cerebral cortex

Research Institute at Nationwide Children's Hospital to receive transition-to-scale grants

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Newsletters you may be interested in